Kristie Lauterbach was appointed Vice President of Quality Assurance for Rein Therapeutics in 2024. Kristie has progressive experience in Manufacturing and Quality Assurance Operations with over 25 years in the pharmaceutical industry. Prior to Rein Therapeutics, Kristie provided guidance and leadership spanning across Quality Assurance, Manufacturing, Validation, Quality Control, Supplier and Vendor Management, and Regulatory inspection preparedness and conduct.
She has worked for major pharmaceutical companies including, Takeda, Catalent Pharma Solutions, Eli Lilly and Company and CSL Behring. Her experience spans from drug discovery and development to commercial manufacturing in biotechnology, parenteral manufacturing, and solid oral dose delivery. Kristie holds a degree in Biology and received her MBA.